PHARA Act of 2025

House Bill

H.R. 4007

119th Congress

PHARA Act of 2025

In Committee

Introduced:Jun 12, 2025

Primary Sponsor

Earl L. Carter

Representative

Republican

GA-1

Cosponsors

9

Quick Stats

Policy Area

Health

Summary

This bill would require the National Institutes of Health (NIH) to immediately release and spend all funding for active and ongoing research grants. It would prohibit the NIH from terminating these grants, and require all new NIH grants to include termination clauses. The bill also bans the NIH from terminating grants based solely on the grants no longer aligning with the agency's priorities.

Latest Action

Referred to the Subcommittee on Health.

SponsorEarl L. Carter (R-GA)

Introduced6/12/2025

StatusReferred to the House Committee on Energy and Commerce.

ChamberHouse

Data from Congress.gov

See this page through your district lens

Enter ZIP to personalize representatives and vote context.

Stay on top of this issue

Subscribe for weekly bill and representative updates.

Vote Prediction

PHARA Act of 2025

This bill would require the National Institutes of Health (NIH) to immediately release and spend all funding for active and ongoing research grants. It would prohibit the NIH from terminating these grants, and require all new NIH grants to include termination

Community Breakdown

Pass

0%

Fail

0%

0 predictions

This bill would require the National Institutes of Health (NIH) to immediately release and spend all funding for active and ongoing research grants. It would prohibit the NIH from terminating these grants, and require all new NIH grants to include termination clauses. The bill also bans the NIH from terminating grants based solely on the grants no longer aligning with the agency's priorities.

Bill Number: 4007
Sponsor: Earl L. Carter (R-GA)
Introduced: 6/12/2025
Status: Referred to the House Committee on Energy and Commerce.
Policy Area: Health

Data from Congress.gov

AI-generated summary

Fact Sheet

Title: PHARA Act of 2025
Bill Number: 4007
Sponsor: Earl L. Carter (R-GA)
Status: Referred to the House Committee on Energy and Commerce.
Introduced: 6/12/2025
Summary: This bill would require the National Institutes of Health (NIH) to immediately release and spend all funding for active and ongoing research grants. It would prohibit the NIH from terminating these grants, and require all new NIH grants to include termination clauses. The bill also bans the NIH from

Data from Congress.gov

AI Summary

Plain-English explanation of this bill

This bill would require the National Institutes of Health (NIH) to immediately release and spend all funding for active and ongoing research grants. It would prohibit the NIH from terminating these grants, and require all new NIH grants to include termination clauses. The bill also bans the NIH from terminating grants based solely on the grants no longer aligning with the agency's priorities.

Last updated: 12/30/2025

Official Summary

Congressional Research Service summary

Halting the Epidemic of Addiction and Loss Act of 2023 or the HEAL Act of 2023This bill requires the Department of Health and Human Services (HHS) to ensure that references in its grant programs to opioid overdose reversal agents are inclusive of any such agents that have been approved by the Food and Drug Administration (FDA).Specifically, HHS must ensure that regulations, guidance, and other documents for grant programs that include references to opioid overdose reversal agents (e.g., naloxone) encompass any opioid overdose reversal agent that has been approved by the FDA. HHS must also update such references with respect to materials that were previously issued for State Opioid Response Grants, Tribal Opioid Response Grants, and Programs of Regional and National Significance for substance use disorder prevention.

Key Points

Main provisions of the bill

Requires the NIH to immediately release and spend all funding for active and ongoing research grants
Prohibits the NIH from terminating active and ongoing research grants
Requires all new NIH grants to include termination clauses
Bans the NIH from terminating grants based solely on the grants no longer aligning with the agency's priorities

How This Impacts Americans

Potential effects on citizens and communities

If this bill becomes law, it would protect ongoing medical and scientific research projects funded by the NIH from being abruptly terminated, even if the projects no longer align with the agency's current priorities. This would benefit researchers, universities, and medical institutions that rely on NIH grants, as well as the patients and public who benefit from the research.

Policy Areas

Primary Policy Area

Health

Related Subjects

Drug therapy

Drug trafficking and controlled substances

Drug, alcohol, tobacco use

Government information and archives

Scope & Jurisdiction

Jurisdiction Level

federal

Congressional Session

119th Congress

Citation Reference

4007, 119th Congress (2025). "PHARA Act of 2025". Source: Voter's Right Platform. https://votersright.org/bills/118-hr-4007

Public Opinions

Community submissions related to this bill.

Share your opinion

No public opinions yet. Be the first to submit one for this bill.

Related Bills in Health

HR 3021

Empowering Patient Choice of Medical Care Act

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means

HR 2111

To amend the Federal Food, Drug, and Cosmetic Act to exempt the premium cigar industry from certain regulations.

Referred to the House Committee on Energy and Commerce.

HR 2884

Anti-Racism in Public Health Act of 2025

Referred to the House Committee on Energy and Commerce.

S 1406

SOAR Act of 2025

Read twice and referred to the Committee on Finance.